Affymax, Inc.
$0.00-9.09%($-0.00)
TickerSpark Score
69/100
100
Valuation
80
Profitability
55
Growth
52
Health
60
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AFFY research report →
52-Week Range31% of range
Low $0.00
Current $0.00
High $0.00
Companywww.affymax.com
Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States.
- CEO
- Jonathan Couchman
- IPO
- 2006
- Employees
- 2
- HQ
- New York City, NY, US
Price Chart
+25.00% · this period
Valuation
- Market Cap
- $37.49K
- P/E
- -0.00
- P/S
- 0.03
- P/B
- -0.03
- EV/EBITDA
- 0.39
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 99.12%
- Op Margin
- -1099.05%
- Net Margin
- -1053.62%
- ROE
- -420.95%
- ROIC
- 916.52%
Growth & Income
- Revenue
- $1.37M · -98.55%
- Net Income
- $-14,424,000 · 84.56%
- EPS
- $-0.39 · 84.82%
- Op Income
- $-15,046,000
- FCF YoY
- -63.28%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 7.48
- Avg Volume
- 1.46K
Get TickerSpark's AI analysis on AFFY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 28, 13 | WALKER JOHN PETER | sell | 16,040 |
| Aug 28, 13 | WALKER JOHN PETER | sell | 500 |
| Jun 27, 13 | Orwin John A | other | 16,334 |
| Jun 28, 13 | Orwin John A | other | 15,000 |
| Feb 15, 13 | Knapp Jeffrey H | other | 1,015 |
| Feb 15, 13 | Knapp Jeffrey H | other | 313 |
| Feb 15, 13 | Knapp Jeffrey H | other | 1,000 |
| Feb 15, 13 | Knapp Jeffrey H | other | 1,015 |
| Feb 15, 13 | Knapp Jeffrey H | sell | 2,328 |
| Feb 15, 13 | Knapp Jeffrey H | other | 1,000 |
Our AFFY Coverage
We haven't published any research on AFFY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AFFY Report →Similar Companies
ITMC+0.00%
Itoco Inc.
$0.00
ENDV+0.00%
Endonovo Therapeutics, Inc.
$0.00
AMBS+0.00%
Amarantus BioScience Holdings, Inc.
$0.00
BSSP+0.00%
Baseline Productions, Inc.
$0.00
NSPDF+0.00%
Naturally Splendid Enterprises Ltd.
$0.04
CNBX+33.33%
CNBX Pharmaceuticals Inc.
$0.00
GNLKQ+0.00%
GeneLink, Inc.
$0.00
WIBFF+0.00%
West Island Brands Inc.
$0.00